Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EGF mutant receptor vIII as a molecular target in cancer therapy.

× No keyword cloud information.

100 in total

1. EGFR, CD10 and proliferation marker Ki67 expression in ameloblastoma: possible role in local recurrence.

Authors: Azza Abdel-Aziz; Maha M Amin
Journal: Diagn Pathol Date: 2012-02-02 Impact factor: 2.644

2. Identification of EGFRvIII-derived CTL epitopes restricted by HLA A0201 for dendritic cell based immunotherapy of gliomas.

Authors: An-hua Wu; Jing Xiao; Lars Anker; Walter A Hall; Dale S Gregerson; Webster K Cavenee; Wei Chen; Walter C Low
Journal: J Neurooncol Date: 2006-01 Impact factor: 4.130

Review 3. shRNA and siRNA delivery to the brain.

Authors: William M Pardridge
Journal: Adv Drug Deliv Rev Date: 2007-03-16 Impact factor: 15.470

Review 4. Defining the cancer master switch.

Authors: Courtney J Balentine; David H Berger; Shi-He Liu; Changyi Chen; John Nemunaitis; F Charles Brunicardi
Journal: World J Surg Date: 2011-08 Impact factor: 3.352

5. Impact of single-chain Fv antibody fragment affinity on nanoparticle targeting of epidermal growth factor receptor-expressing tumor cells.

Authors: Yu Zhou; Daryl C Drummond; Hao Zou; Mark E Hayes; Gregory P Adams; Dmitri B Kirpotin; James D Marks
Journal: J Mol Biol Date: 2007-05-10 Impact factor: 5.469

6. The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.

Authors: Yi Zhan; George J Counelis; Donald M O'Rourke
Journal: Exp Cell Res Date: 2009-05-08 Impact factor: 3.905

7. Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys.

Authors: Yiting Zhang; Jianhua Sun; Minjia Tan; Yongzhen Liu; Qian Li; Hua Jiang; Huamao Wang; Zonghai Li; Wei Wan; Hualiang Jiang; Henglei Lu; Bingshun Wang; Jin Ren; Likun Gong
Journal: Mol Ther Date: 2018-04-07 Impact factor: 11.454

Review 8. Mechanisms of action of therapeutic antibodies for cancer.

Authors: J M Redman; E M Hill; D AlDeghaither; L M Weiner
Journal: Mol Immunol Date: 2015-04-23 Impact factor: 4.407

9. Epithelial Growth Factor Receptor Inhibitors for treatment of recurrent or progressive high grade glioma: an exploratory study.

Authors: M Preusser; E Gelpi; A Rottenfusser; K Dieckmann; G Widhalm; W Dietrich; A Bertalanffy; D Prayer; J A Hainfellner; Christine Marosi
Journal: J Neurooncol Date: 2008-05-06 Impact factor: 4.130

Review 10. Interaction of antibodies with ErbB receptor extracellular regions.

Authors: Karl R Schmitz; Kathryn M Ferguson
Journal: Exp Cell Res Date: 2008-10-22 Impact factor: 3.905